Professional
Added to YB: 2025-12-08
Pitch date: 2025-12-05
SMTI [bullish]
Sanara MedTech Inc.
+17.99%
current return
Author Info
White Brook is a small/mid-cap investment manager that maintains a concentrated portfolio of 8-15 positions in companies valued between $1-18 billion, focusing on undervalued stocks with improving business fundamentals and holding them long-term. The firm follows an ethical investment approach, avoiding sectors like defense and companies with poor environmental or customer relations records. Sign up for the newsletter.
Company Info
Sanara MedTech Inc., a medical technology company, develops, markets, and distributes surgical, wound, and skincare products and services to physicians, hospitals, clinics, and post-acute care settings in the United States.
Market Cap
$194.4M
Pitch Price
$21.96
Price Target
44.00 (+70%)
Dividend
N/A
EV/EBITDA
40.50
P/E
-30.77
EV/Sales
2.23
Sector
Health Care Equipment and Supplies
Category
growth
Sanara Medtech ($SMTI) 2-3x
SMTI: White Brook position taken. Wound care co w/ Cellerate +20% growth potential vs 17% consensus. 1.8x revenue, 10.8x EBITDA despite superior growth. Chemo Mouthpiece opportunity could double intrinsic value. FCF generation starts 2026. Management improved under new CEO Seth Yon. Board composition & founder control present risks.
Read full article (9 min)